Research ArticleResearch Article: Negative Results, Neuronal Excitability

Reported Benefits of Low-Dose Naltrexone Appear to Be Independent of the Endogenous Opioid System Involving Proopiomelanocortin Neurons and β-Endorphin

Marissa J. Metz, Caitlin M. Daimon and Shane T. Hentges
eNeuro 24 May 2021, 8 (3) ENEURO.0087-21.2021; https://doi.org/10.1523/ENEURO.0087-21.2021

Article Information

DOI 
https://doi.org/10.1523/ENEURO.0087-21.2021
PubMed 
34031099
Published By 
Society for Neuroscience
History 
  • Received March 6, 2021
  • Revision received May 8, 2021
  • Accepted May 14, 2021
  • Published online May 24, 2021.
Copyright & Usage 
Copyright © 2021 Metz et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.

Author Information

  1. Marissa J. Metz,
  2. Caitlin M. Daimon and
  3. Shane T. Hentges
  1. Department of Biomedical Sciences and Program in Molecular, Cellular, and Integrative Neurosciences, Colorado State University, Fort Collins, CO 80523
  1. Correspondence should be addressed to Shane T. Hentges at shane.hentges{at}colostate.edu.
View Full Text

Author contributions

  1. Author contributions: S.T.H. and M.J.M. designed research; M.J.M. and C.M.D. performed research; M.J.M. and C.M.D. analyzed data; S.T.H. and M.J.M. wrote the paper.

Disclosures

  • The authors declare no competing financial interests.

  • This work was supported by the National Science Foundation Grant DGE-1321845 (to M.J.M.) and the National Institutes of Health Grant R01DA032562 (to S.T.H.).

Funding

  • National Science Foundation (NSF)

    DGE-1321845

  • HHS | NIH | National Institute on Drug Abuse (NIDA)

    R01DA032562

Other Version

Online Impact

 

Article usage

Article usage: May 2021 to December 2024

AbstractFullPdf
May 2021145061
Jun 2021378231113
Jul 202110935245
Aug 20213235040
Sep 2021929143
Oct 2021430547
Nov 2021732253
Dec 2021123147
Total 20216852082449
Jan 2022722326
Feb 2022717028
Mar 2022714747
Apr 2022513431
May 2022316141
Jun 2022414918
Jul 2022210726
Aug 2022810444
Sep 202257721
Oct 2022510532
Nov 2022810226
Dec 202248341
Total 2022651562381
Jan 2023110312
Feb 2023310820
Mar 2023510619
Apr 2023410919
May 2023211523
Jun 2023210215
Jul 2023811732
Aug 2023611940
Sep 2023410634
Oct 2023412018
Nov 2023614321
Dec 2023414037
Total 2023491388290
Jan 20241712632
Feb 2024910929
Mar 2024510329
Apr 202489638
May 2024712929
Jun 20241010726
Jul 202499330
Aug 2024810032
Sep 202469516
Oct 20241210821
Nov 20241211616
Dec 2024041
Total 20241031186299
Total90262181419
Back to top

In this issue

Email
Print
View Full Page PDF
Citation Tools
Respond to this article
Reported Benefits of Low-Dose Naltrexone Appear to Be Independent of the Endogenous Opioid System Involving Proopiomelanocortin Neurons and β-Endorphin
Marissa J. Metz, Caitlin M. Daimon, Shane T. Hentges
eNeuro 24 May 2021, 8 (3) ENEURO.0087-21.2021; DOI: 10.1523/ENEURO.0087-21.2021
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Subjects